<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/81AD63AF-6126-448E-ADD5-05CAA6ECD32E"><gtr:id>81AD63AF-6126-448E-ADD5-05CAA6ECD32E</gtr:id><gtr:firstName>Jonathon</gtr:firstName><gtr:surname>Pines</gtr:surname><gtr:orcidId>0000-0002-5227-6004</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400656"><gtr:id>3E76CE50-4D1E-4AE0-A127-18ECB109EE17</gtr:id><gtr:title>Real time analysis of mitotic protein kinase activity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400656</gtr:grantReference><gtr:abstractText>This study aims to generate the means to measure the activity of the factor that drives cells to divide into two, and, most importantly, to measure this activity in living cells as they divide. This had not been possible until recent advances in imaging techniques. Through this we hope to gain a better understanding of how cells coordinate the dramatic change in their architecture required to separate the genome into two identical copies and faithfully pass one intact copy to each of the two daughter cells. This process can go wrong in diseases such as cancer, and is related to the problem that gives rise to the extra copy of chromosome 21 that causes Down?s syndrome. Thus, a better understanding of how cells control their division may help in designing ways to combat cancer and to understand how some genetically inherited syndromes are caused.</gtr:abstractText><gtr:technicalSummary>This proposal seeks to refine our understanding of the mechanisms that regulate cell division. It will generate the means to analyse the activity of specific protein kinases in real time in living cells, focusing on the mitotic kinases that regulate cell division. We will assay in both space and time the activation and the subsequent activity of the mitotic protein kinases as cells divide. This is both timely and important as it will build on a number of studies, from our own and other laboratories that have provided evidence that the mitotic machinery may be spatially as well as temporally regulated. We will make use of recent advances in both imaging technology, such as the advent of FRET-based biosensors, and in our understanding of how phosphorylation on serine and threonine can create binding sites for particular protein domains, to design assays for specific protein kinases in living cells. These analyses will be crucial to a proper understanding of how cellular events are controlled and coordinated by phosphorylation and dephosphorylation.</gtr:technicalSummary><gtr:fund><gtr:end>2008-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>202023</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Core grant seminar</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E623E22A-5149-4E52-A85C-7028AA5C9A0F</gtr:id><gtr:impact>Presented our research to the administrative and support staff at our Institute

Very positive feedback from audience members</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>266692</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800033</gtr:fundingRef><gtr:id>B610E106-7732-43F0-BE17-94661E03200B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a live-cell probe to measure the activity of the cyclin B1-Cdk1 kinase in living cells. This probe increases its emission in the green spectrum due to Forster resonance transfer energy when the cyclin B1-Cdk1 kinase is activated.</gtr:description><gtr:id>9FE81A01-24AF-4FFB-BBD6-364334FC90EB</gtr:id><gtr:impact>We are for the first time able to measure cyclin B1-Cdk1 kinase activity in living cells.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>FRET biosensor</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/560ECB4C-B4E7-45B2-8E01-5832F1A8B743"><gtr:id>560ECB4C-B4E7-45B2-8E01-5832F1A8B743</gtr:id><gtr:title>Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25234f4b8a1f93f6858874d1a04f6777"><gtr:id>25234f4b8a1f93f6858874d1a04f6777</gtr:id><gtr:otherNames>Gavet O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3381E68-EBBB-44AC-8A33-85AE4AEDCD87"><gtr:id>B3381E68-EBBB-44AC-8A33-85AE4AEDCD87</gtr:id><gtr:title>Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25234f4b8a1f93f6858874d1a04f6777"><gtr:id>25234f4b8a1f93f6858874d1a04f6777</gtr:id><gtr:otherNames>Gavet O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400656</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>